Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Centessa Pharmaceuticals (CNTA) Prepaid Assets (2022 - 2025)

Centessa Pharmaceuticals (CNTA) has disclosed Prepaid Assets for 4 consecutive years, with $1.8 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 22.21% to $1.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, up 22.21% year-over-year, with the annual reading at $1.8 million for FY2025, 22.21% up from the prior year.
  • Prepaid Assets for Q4 2025 was $1.8 million at Centessa Pharmaceuticals, down from $2.8 million in the prior quarter.
  • The five-year high for Prepaid Assets was $22.7 million in Q3 2023, with the low at $1.1 million in Q1 2022.
  • Average Prepaid Assets over 4 years is $7.5 million, with a median of $2.3 million recorded in 2024.
  • Peak annual rise in Prepaid Assets hit 1658.77% in 2023, while the deepest fall reached 91.87% in 2023.
  • Over 4 years, Prepaid Assets stood at $19.9 million in 2022, then crashed by 91.87% to $1.6 million in 2023, then decreased by 7.77% to $1.5 million in 2024, then rose by 22.21% to $1.8 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $1.8 million, $2.8 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.